GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Star Combo Pharma Ltd (ASX:S66) » Definitions » EV-to-FCF

Star Combo Pharma (ASX:S66) EV-to-FCF : 3.08 (As of Mar. 26, 2025)


View and export this data going back to 2018. Start your Free Trial

What is Star Combo Pharma EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Star Combo Pharma's Enterprise Value is A$12.79 Mil. Star Combo Pharma's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was A$4.15 Mil. Therefore, Star Combo Pharma's EV-to-FCF for today is 3.08.

The historical rank and industry rank for Star Combo Pharma's EV-to-FCF or its related term are showing as below:

ASX:S66' s EV-to-FCF Range Over the Past 10 Years
Min: -19.79   Med: -5.49   Max: 3.25
Current: 3.25

During the past 8 years, the highest EV-to-FCF of Star Combo Pharma was 3.25. The lowest was -19.79. And the median was -5.49.

ASX:S66's EV-to-FCF is ranked better than
93.57% of 1197 companies
in the Consumer Packaged Goods industry
Industry Median: 17.5 vs ASX:S66: 3.25

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-03-26), Star Combo Pharma's stock price is A$0.16. Star Combo Pharma's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was A$0.007. Therefore, Star Combo Pharma's PE Ratio (TTM) for today is 22.86.


Star Combo Pharma EV-to-FCF Historical Data

The historical data trend for Star Combo Pharma's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Star Combo Pharma EV-to-FCF Chart

Star Combo Pharma Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
EV-to-FCF
Get a 7-Day Free Trial -8.75 -2.94 -2.16 -11.42 -6.66

Star Combo Pharma Semi-Annual Data
Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -11.42 - -6.66 -

Competitive Comparison of Star Combo Pharma's EV-to-FCF

For the Household & Personal Products subindustry, Star Combo Pharma's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Star Combo Pharma's EV-to-FCF Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Star Combo Pharma's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Star Combo Pharma's EV-to-FCF falls into.



Star Combo Pharma EV-to-FCF Calculation

Star Combo Pharma's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=12.792/4.147
=3.08

Star Combo Pharma's current Enterprise Value is A$12.79 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Star Combo Pharma's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was A$4.15 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Star Combo Pharma  (ASX:S66) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Star Combo Pharma's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.16/0.007
=22.86

Star Combo Pharma's share price for today is A$0.16.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Star Combo Pharma's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was A$0.007.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Star Combo Pharma EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Star Combo Pharma's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Star Combo Pharma Business Description

Traded in Other Exchanges
N/A
Address
171 - 177 Woodpark Road, Smithfield, Sydney, NSW, AUS, 2164
Star Combo Pharma Ltd is engaged in the manufacturing and distribution of food products and nutritional supplements. The company offers products such as face masks, moisturizing creams, serums, concentrates, and oils. Star Combo Pharma markets its products. It operates in two segments. Star Combo segment engages in the development, manufacturing, marketing and sales of natural health supplements and skincare products. The Austoyou retail business segment has made up of the Australia-China e-commerce platform that offers product lines directly to Chinese health product consumers; and Koala Mall's two retail stores in Sydney. Geographically, it operates in China and Australia.

Star Combo Pharma Headlines

No Headlines